Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
RESEARCH TOOLSreports
Holding DAWN?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 93.76M | $ 8.19M | - | - | - |
| Gross Profit | $ 93.76M | $ 8.19M | - | - | - |
| EBIT | $ 36.16M | $ -2.85M | $ -66.77M | $ -59.52M | $ -46.15M |
| EBITDA | $ 36.90M | $ -1.16M | $ -66.65M | $ -59.41M | $ -46.05M |
| Net Income Common Stockholders | $ 37.04M | $ -3.70M | $ -62.41M | $ -54.51M | $ -46.15M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 558.38M | $ 361.87M | $ 317.94M | $ 366.35M | $ 405.54M |
| Total Assets | $ 600.81M | $ 400.44M | $ 326.64M | $ 376.05M | $ 414.18M |
| Total Debt | $ 2.62M | $ 190.00K | $ 300.00K | $ 408.00K | $ 514.00K |
| Net Debt | $ -555.77M | $ -361.68M | $ -317.64M | $ -365.94M | $ -405.02M |
| Total Liabilities | $ 45.34M | $ 93.71M | $ 29.84M | $ 29.51M | $ 24.55M |
| Stockholders Equity | $ 555.46M | $ 306.73M | $ 296.81M | $ 346.54M | $ 389.63M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 158.03M | $ -66.25M | $ -49.73M | $ -41.38M | $ -37.10M |
| Operating Cash Flow | $ 50.75M | $ -49.13M | $ -49.73M | $ -41.37M | $ -37.06M |
| Investing Cash Flow | $ -67.70M | $ 17.06M | $ 89.29M | $ 30.38M | $ 88.92M |
| Financing Cash Flow | $ 200.09M | $ 1.30M | $ 48.00K | $ 597.00K | $ 115.00K |